New York Firm Raises $48 Million To Develop New Cancer Immunotherapies – Forbes

Forbes… at Weill Cornell Medical by Laurie Glimcher, who was previously dean there and is now chief executive of the Dana-Farber Cancer Institute in Boston, and Juan Cubillos-Ruiz, an assistant professors of microbiology and immunonology. In Quentis … and more …read more Source:: New York City News By Google News

from WordPress http://zennie62blog.com/2018/02/27/new-york-firm-raises-48-million-to-develop-new-cancer-immunotherapies-forbes/
via IFTTT